Quick Answer
NEUROONE MEDICAL TECHNOLOGIES Corp reported Operating Income of -$4.23 million for fiscal year 2025.
NEUROONE MEDICAL TECHNOLOGIES Corp Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$4.23M | +64.4% |
| 2024 | -$11.89M | +0.6% |
| 2023 | -$11.96M | -19.2% |
| 2022 | -$10.03M | +1.8% |
| 2021 | -$10.22M | -108.4% |
| 2020 | -$4.90M | +15.7% |
| 2019 | -$5.81M | -17726.5% |
| 2016 | -$32.6K | -5.5% |
| 2015 | -$30.9K | +13.9% |
| 2014 | -$35.9K | -43.1% |
| 2013 | -$25.1K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$1.71M | -199.8% | +9.5% |
| June 30, 2025 | -$1.89M | +32.5% | +29.6% |
| March 31, 2025 | -$2.68M | +7.1% | -256.6% |
| December 31, 2024 | $1.71M | +150.5% | +161.2% |
| June 30, 2024 | -$2.79M | +20.4% | +3.2% |
| March 31, 2024 | -$2.89M | +17.4% | +14.9% |
| December 31, 2023 | -$3.39M | -90.0% | +3.4% |
| June 30, 2023 | -$3.51M | -27.1% | -0.4% |
- NEUROONE MEDICAL TECHNOLOGIES Corp showed an increase of +64.4% in Operating Income compared to the prior fiscal year.
- Over the 2013–2025 period, NEUROONE MEDICAL TECHNOLOGIES Corp’s operating income has declined by 16743.2% (from -$25.1 thousand to -$4.23 million).
- The most recent figure is from NEUROONE MEDICAL TECHNOLOGIES Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: